RESEARCH-USE BIOSIMILAR ANTIBODY
Trinbelimab
Monoclonal antibody · IgG1
Trinbelimab (r-anti-D) is a recombinant anti-D immunoglobulin that targets the RhD antigen. Trinbelimab exerts immunosuppressive effects to block maternal-fetal RhD alloimmunization. Trinbelimab can be used for the study of maternal-fetal immunity associated with RhD incompatibility.
TARGETRhD
YMonoclonal antibody
CATALOGSC-BS-084
CATALOG NUMBERSC-BS-084
MOLECULAR WEIGHTApprox. 145.47 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Trinbelimab (r-anti-D) is a recombinant anti-D immunoglobulin that targets the RhD antigen. Trinbelimab exerts immunosuppressive effects to block maternal-fetal RhD alloimmunization. Trinbelimab can be used for the study of maternal-fetal immunity associated with RhD incompatibility.
Trinbelimab is a recombinant research-use antibody directed against RhD.